Ribociclib 200mg 1 Box [Prescription Required]

KRYXANA Ribociclib 200mg 1 Box

Ribociclib (Kryxana?) is (a cyclin-dependent kinase inhibitor, CDKi) indicated for the treatment of patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2) negative (locally) advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant.
In pre or peri-menopausal women, the endocrine therapy should be combined with a luteinizing hormone-releasing hormone (LHRH) agonist.

Origin

Singapore

Product Usage

The recommended dose is 600 mg (3 x 200 mg film-coated tablets) taken orally, once daily for 21 consecutive days followed by 7 days off treatment resulting in a complete cycle of 28 days. Ribociclib can be taken with or without food (see section INTERACTIONS).

Ingredients

Active Substance: Ribociclib Excipients: Tablet core Microcrystalline cellulose; low-substituted hydroxypropylcellulose; crospovidone (Type A); colloidal silicon dioxide; magnesium stearate., Coating material: Polyvinyl alcohol (partially hydrolysed); titanium dioxide (E171); iron oxide black (E172); iron oxide red (E172); talc: lecithin (soy) (E322); xanthan gum.

Warnings

Ribociclib is contraindicated in patients with hypersensitivity to the active substance

Width

1

Height

1

Depth

1